Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Drug repurposing finds new uses for existing drugs, speeding up treatment availability and reducing costs.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Reprogramming wound-repair cells can improve healing of chronic wounds.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Timely, tailored treatment is crucial for managing drug overdoses effectively.

Bubble microneedles effectively deliver drugs through the skin and mouth, improving treatment speed and efficiency.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Personalized treatment plans are important for people with alopecia areata.

Adalimumab helped control a child's severe eye disease when other treatments failed.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Topical creams are commonly used for treating non-infective skin diseases in children, with antifungals being the most prescribed.

The evaluation system improved patient selection for hair loss surgery, leading to better results and satisfaction.

Topical immunotherapy with SADBE and DPCP is most effective for short-term hair regrowth in children with severe alopecia areata.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A biomarker-guided approach can improve alopecia treatment by targeting specific pathways.

New natural remedies for hair loss prevention and treatment were developed.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.